Center for Neurodegeneration and Experimental Therapeutics
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:affiliatedWith |
gptkb:University_of_Alabama_at_Birmingham
|
| gptkbp:aimsTo |
improve patient outcomes
advance scientific knowledge develop new therapies enhance understanding of neurodegeneration |
| gptkbp:collaboratesWith |
pharmaceutical companies
|
| gptkbp:conducts |
clinical research studies
preclinical research studies |
| gptkbp:conductsResearchOn |
gptkb:Huntington's_disease
Alzheimer's disease Parkinson's disease |
| gptkbp:engagesIn |
community outreach
|
| gptkbp:focusesOn |
neurodegenerative diseases
|
| gptkbp:hasAccessTo |
advanced technologies
state-of-the-art equipment |
| gptkbp:hasEstablished |
partnerships with other institutions
therapeutic development programs biomarker_discovery_programs |
| gptkbp:hasPart |
administrative offices
laboratory facilities clinical facilities |
| gptkbp:hasResearchFocus |
environmental factors
genetic factors neuroinflammation neuroprotection cellular mechanisms |
| gptkbp:hosts |
scientific conferences
|
| https://www.w3.org/2000/01/rdf-schema#label |
Center for Neurodegeneration and Experimental Therapeutics
|
| gptkbp:isInvolvedIn |
data analysis
patient care policy advocacy biostatistics clinical trials for new drugs patient recruitment for studies |
| gptkbp:isLedBy |
director
|
| gptkbp:isPartOf |
gptkb:UAB_Research_Enterprise
|
| gptkbp:isRecognizedFor |
innovative research
|
| gptkbp:isSupportedBy |
clinical staff
research staff administrative staff |
| gptkbp:locatedIn |
gptkb:Birmingham,_Alabama
|
| gptkbp:offers |
clinical trials
fellowship programs internship programs |
| gptkbp:participatesIn |
international collaborations
|
| gptkbp:provides |
educational resources
patient support services |
| gptkbp:publishes |
scientific papers
|
| gptkbp:receivesFundingFrom |
government grants
private donations |